PerioMonitor™ is a rapid, non-invasive, in-office, saliva-based test. It measures the patient’s leukocyte esterase level that is associated with active periodontal disease. PerioMonitor™ does not require a laboratory or device.PerioMonitor™ est un test rapide, non-invasif, effectué en clinique à partir de la salive. Il mesure le niveau d’estérase leucocytaire, un marqueur associé à une maladie parodontale active. PerioMonitor™ ne nécessite aucun envoi en laboratoire ou appareil.
375 patients in 4 dental offices375 patients dans 4 cliniques dentaires
Test results were compared to the Bleeding on Probing (BOP) methodLes résultats des tests ont été comparés à la méthode du saignement au sondage (BOP)
PerioMonitor™ has been developed under the leadership and research of Dr. Michael Glogauer, a renowned Toronto-based periodontist, Chief of Dentistry for the University Health Network and Head of Dental Oncology at the Princess Margaret Cancer Centre.PerioMonitor™ a été mis au point sous la direction et les recherches du Dr Michael Glogauer, un parodontiste renommé basé à Toronto, Chef du service de dentisterie de l’University Health Network et Responsable de l'oncologie dentaire au Princess Margaret Cancer Centre.
“PerioMonitor is the missing link in patient periodontal treatment acceptance, aligning with Oral Science’s mission to provide evidence-based solutions that enhance clinical outcomes.”«PerioMonitor est le maillon manquant dans l'acceptation du traitement parodontal par les patients, s'alignant sur la mission de Oral Science : fournir des solutions fondées sur des preuves scientifiques afin d'améliorer les résultats cliniques.»
— Daniel Ménard, CEO & Co-Founder of Oral Science, Distributor of PerioMonitor™président et co-fondateur de Oral Science, distributeur de PerioMonitor™
PerioMonitor™ is a rapid, non-invasive, point-of-care test designed to detect oral inflammation through the measurement of neutrophil enzyme activity (NEA) in saliva. Developed by Oral Science, the test empowers clinicians with real-time, objective data on oral inflammatory load (OIL), transforming how periodontal disease is screened, diagnosed, and monitored.
Read moreLire la suitePeriodontal disease remains one of the most common chronic conditions globally, affecting nearly half of adults over age 30 and more than 70% of seniors. Yet despite its prevalence and impact, traditional diagnostic tools—such as periodontal probing and radiographs—primarily identify historical tissue destruction rather than ongoing inflammation.
Read moreLire la suiteOral polymorphonuclear neutrophil (oPMN) levels are potential biomarkers for differentiating between stages and grades of periodontitis. We compared the diagnostic utility of oPMN levels with bleeding on probing percentage (BOP%) and microbial load in high-risk patients with periodontitis.
Read moreLire la suitePeriodontal diseases are chronic inflammatory conditions that require early screening for effective long-term management. Oral neutrophil counts (ONCs) correlate with periodontal inflammation. This study investigates a point-of-care test using a neutrophil enzyme activity (NEA) colorimetric strip for measuring periodontal inflammation.
Read moreLire la suiteLive on at
This webinar will show you how to help patients understand their periodontal disease status. You will learn how to explain to patients why testing for inflammation with PerioMonitor is valuable — even when there may be minimal oral symptoms. You will be given the tools to present salivary test results in simple language/scripting. This conversation will assist you in connecting oral health and inflammation to whole body health. The Patient’s understanding of their disease status via the color marker in Periomonitor will increase their compliance to follow through with necessary therapy and may increase the frequency of recall visits to ensure that their health is maintained.
Dr. Michael Glogauer
Chief of Dentistry for the University Health Network and Head of Dental Oncology at the Princess Margaret Cancer Centre.
Dr. Samuel B. Low, DDS MS MEd
PerioMonitor measures oral neutrophils—white blood cells released in response to local inflammation in the mouth. It provides an objective snapshot of oral inflammation from conditions like gingivitis, periodontitis, or peri-implant disease.PerioMonitor mesure les neutrophiles buccaux — des globules blancs libérés en réponse à une inflammation locale dans la bouche. Il offre un aperçu objectif de l’inflammation buccale liée à des affections comme la gingivite, la parodontite ou la maladie péri-implantaire.
View our
Integration guideConsultez notre
Guide d’intégration
No. The test is accurate if you follow the 15 second pre-rinse and 2 minute wait.Non. Le test est fiable si vous respectez le prélavage de 15 secondes et l’attente de 2 minutes.
Yes. Peri-implant disease often causes more inflammation—monitor implants closely.Oui. La maladie péri-implantaire provoque souvent davantage d’inflammation—surveillez les implants de près.
No. But these conditions can worsen oral inflammation, which PerioMonitor detects.Non. Mais ces affections peuvent aggraver l’inflammation buccale, que PerioMonitor détecte.
No. They may reduce symptoms, but PerioMonitor still detects true inflammation.Non. Ils peuvent atténuer les symptômes, mais PerioMonitor détecte toujours l’inflammation réelle.
No. They don’t affect oral neutrophils, so the test remains accurate.Non. Ils n’affectent pas les neutrophiles buccaux, le test reste donc fiable.
No direct effect, but these can raise oral inflammation, which may increase results.Pas d’effet direct, mais ils peuvent accroître l’inflammation buccale, ce qui peut augmenter les résultats.
No. But they can impact oral health behavior or immune response, indirectly raising inflammation.Non. Mais ils peuvent modifier les comportements d’hygiène buccale ou la réponse immunitaire, augmentant indirectement l’inflammation.
No. The test fluid captures neutrophils from gingival crevices—not saliva.Non. Le fluide du test capture les neutrophiles provenant des sillons gingivaux—pas la salive.
Only if it’s actively bleeding—otherwise, no effect.Uniquement en cas de saignement actif—sinon, aucun effet.
Only if pus or exudate is draining into the mouth—it contains neutrophils.Uniquement s’il existe un écoulement de pus/exsudat dans la bouche—il contient des neutrophiles.
It could be early gingivitis (initial preclinical stage) or other causes like candidiasis, oral cancer, or lichen planus. Retest in 4 weeks if unclear.Il peut s’agir d’une gingivite précoce (stade préclinique initial) ou d’autres causes comme une candidose, un cancer buccal ou un lichen plan. Refaire le test dans 4 semaines si le doute persiste.
Usually at 4–6 weeks, or as early as 2 weeks if needed.Habituellement après 4 à 6 semaines, ou dès 2 semaines si nécessaire.
Yes. Conditions like denture trauma can raise inflammation. It's a good tool for motivating better hygiene habits.Oui. Des situations comme les traumatismes liés aux prothèses peuvent accroître l’inflammation. C’est un bon outil pour motiver de meilleures habitudes d’hygiène.
A sinus infection will NOT affect a PM result. For teeth with non-reversible pulpitis: if the infection is contained within the tooth, it will not affect PerioMonitor. If the tooth has a draining fistula, it will affect PerioMonitor—exudate is full of neutrophils.Une sinusite n’affectera PAS le résultat PM. Pour une dent avec pulpite irréversible : si l’infection est confinée à la dent, elle n’affectera pas PerioMonitor. Si la dent présente une fistule drainante, cela affectera PerioMonitor—l’exsudat est riche en neutrophiles.
Contact Dr. Michael Glogauer: Contactez Dr Michael Glogauer : michael.glogauer@dentistry.utoronto.ca